Glaxo Takes $3.4 Billion Charge on Legal Problems
Monday, January 17, 2011 - 12:40
in Health & Medicine
The move, prompted by claims over the diabetes drug Avandia and inquiries into sales practices, will effectively wipe out its quarterly profits.